Cite
HARVARD Citation
Hasegawa, C. et al. (n.d.). Modeling and simulation of bone mineral density response from a phase 2 study of ONO‐5334, a new cathepsin K inhibitor, to support dose selection in osteoporosis. Journal of clinical pharmacology. pp. 937-948. [Online].